• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测定头孢妥仑匹酯的稳定性指示液相色谱-紫外法的开发与验证

Development and validation of the stability-indicating LC-UV method for the determination of Cefditoren pivoxil.

作者信息

Annapurna M Mathrusri, Goutam S V S, Anusha S, Srinivas L

机构信息

Department of Pharmaceutical Analysis & Quality Assurance, GITAM Institute of Pharmacy, GITAM University, Visakhapatnam 530045, India.

出版信息

J Pharm Anal. 2012 Dec;2(6):466-469. doi: 10.1016/j.jpha.2012.06.003. Epub 2012 Jun 27.

DOI:10.1016/j.jpha.2012.06.003
PMID:29403785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5760946/
Abstract

An isocratic RP-HPLC method was developed for the determination of Cefditoren pivoxil in pharmaceutical formulations using a C-18 column with water-acetonitrile (50:50, v/v) as mobile phase and flow rate 1.2 mL/min (UV detection at 218 nm). Linearity was observed in the concentration range 1.0-250 μg/mL (=0.999) with regression equation =24194+10749. The forced degradation studies were performed by using HCl, NaOH, and HO, and thermal and UV radiation. Cefditoren pivoxil is more sensitive towards oxidation and alkaline conditions and resistant towards acidic and photolytic degradations. The method was validated as per ICH guidelines.

摘要

建立了一种等度反相高效液相色谱法,用于测定药物制剂中的头孢妥仑匹伏酯,采用C-18柱,以水-乙腈(50:50,v/v)为流动相,流速为1.2 mL/min(在218 nm处进行紫外检测)。在1.0-250 μg/mL的浓度范围内观察到线性关系(=0.999),回归方程为=24194+10749。通过使用盐酸、氢氧化钠和过氧化氢以及热和紫外线辐射进行强制降解研究。头孢妥仑匹伏酯对氧化和碱性条件更敏感,对酸性和光解降解具有抗性。该方法按照国际人用药品注册技术协调会(ICH)指南进行了验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68f/5760946/cd2fed477a81/fx00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68f/5760946/7dc4eda14b32/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68f/5760946/0c5934afb384/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68f/5760946/1f2669dd75e3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68f/5760946/fb2f7339ead2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68f/5760946/cd2fed477a81/fx00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68f/5760946/7dc4eda14b32/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68f/5760946/0c5934afb384/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68f/5760946/1f2669dd75e3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68f/5760946/fb2f7339ead2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c68f/5760946/cd2fed477a81/fx00.jpg

相似文献

1
Development and validation of the stability-indicating LC-UV method for the determination of Cefditoren pivoxil.用于测定头孢妥仑匹酯的稳定性指示液相色谱-紫外法的开发与验证
J Pharm Anal. 2012 Dec;2(6):466-469. doi: 10.1016/j.jpha.2012.06.003. Epub 2012 Jun 27.
2
Stability-indicating liquid chromatographic method for the determination of Letrozole in pharmaceutical formulations.用于测定药物制剂中来曲唑的稳定性指示液相色谱法。
J Pharm Anal. 2012 Aug;2(4):298-305. doi: 10.1016/j.jpha.2012.01.010. Epub 2012 Feb 3.
3
Development and validation of a stability indicating RP-HPLC method for the determination of Rufinamide.用于测定卢非酰胺的稳定性指示反相高效液相色谱法的建立与验证
J Pharm Anal. 2013 Feb;3(1):66-70. doi: 10.1016/j.jpha.2012.08.003. Epub 2012 Sep 5.
4
Stability-Indicating HPLC Method for the Determination of Cefcapene Pivoxil.用于测定头孢卡品酯的稳定性指示高效液相色谱法
Chromatographia. 2013 Apr;76(7-8):387-391. doi: 10.1007/s10337-012-2318-1. Epub 2012 Sep 18.
5
Development and validation of a stability-indicating RP-HPLC method for estimation of atazanavir sulfate in bulk.用于原料药硫酸阿扎那韦含量测定的稳定性指示反相高效液相色谱法的建立与验证
J Pharm Anal. 2017 Apr;7(2):134-140. doi: 10.1016/j.jpha.2013.12.002. Epub 2013 Dec 31.
6
Development and validation of a stability-indicating RP-HPLC method for the determination of febuxostat (a xanthine oxidase inhibitor).一种用于测定非布索坦(一种黄嘌呤氧化酶抑制剂)的稳定性指示反相高效液相色谱法的开发与验证
J Chromatogr Sci. 2013 Nov-Dec;51(10):931-8. doi: 10.1093/chromsci/bms192. Epub 2012 Dec 2.
7
Development of a Forced Degradation Profile of Alosetron by Single Mode Reversed-Phase HPLC, LC-MS, and its Validation.通过单模反相高效液相色谱法、液相色谱-质谱联用技术建立阿洛司琼强制降解图谱及其验证
Sci Pharm. 2014 Dec 29;83(2):311-20. doi: 10.3797/scipharm.1411-07. Print 2015 Apr-Jun.
8
Identification and Characterization of Hydrolytic Degradation Products of Cefditoren Pivoxil using LC and LC-MS/TOF.使用液相色谱和液相色谱-质谱/飞行时间质谱对头孢妥仑匹酯的水解降解产物进行鉴定和表征
Indian J Pharm Sci. 2015 Jan-Feb;77(1):75-82. doi: 10.4103/0250-474x.151607.
9
Stability indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe in pharmaceutical formulations.用于同时测定药物制剂中瑞舒伐他汀和依折麦布的稳定性指示液相色谱法。
Adv Pharm Bull. 2014 Dec;4(4):405-11. doi: 10.5681/apb.2014.060. Epub 2014 Aug 10.
10
Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Doxofylline and Terbutalinesulphate in Pharmaceutical Formulations.用于同时测定药物制剂中多索茶碱和硫酸特布他林的稳定性指示反相高效液相色谱法
Sci Pharm. 2013 Jul 14;81(4):969-82. doi: 10.3797/scipharm.1305-14. Print 2013 Oct-Dec.

引用本文的文献

1
Rapid and Sensitive Electrochemical Assay of Cefditoren with MWCNT/Chitosan NCs/FeO as a Nanosensor.以MWCNT/壳聚糖纳米复合材料/FeO为纳米传感器的头孢妥仑快速灵敏电化学检测法
Micromachines (Basel). 2022 Aug 19;13(8):1348. doi: 10.3390/mi13081348.
2
Assay method for quality control and stability studies of a new antimalarial agent (CDRI 99/411).一种新型抗疟药(CDRI 99/411)质量控制与稳定性研究的检测方法
J Pharm Anal. 2013 Oct;3(5):335-340. doi: 10.1016/j.jpha.2013.04.003. Epub 2013 May 6.
3
Identification and Characterization of Hydrolytic Degradation Products of Cefditoren Pivoxil using LC and LC-MS/TOF.

本文引用的文献

1
Cefditoren, a new aminothiazolyl cephalosporin.头孢地尼,一种新型氨噻唑基头孢菌素。
Pharmacotherapy. 2002 Oct;22(10):1278-93. doi: 10.1592/phco.22.15.1278.33481.
2
Determination of cefditoren (ME 1206) in the plasma of elderly patients with multiple diseases using high-performance liquid chromatography.采用高效液相色谱法测定患有多种疾病的老年患者血浆中的头孢妥仑(ME 1206)。
Clin Lab. 2000;46(9-10):477-82.
使用液相色谱和液相色谱-质谱/飞行时间质谱对头孢妥仑匹酯的水解降解产物进行鉴定和表征
Indian J Pharm Sci. 2015 Jan-Feb;77(1):75-82. doi: 10.4103/0250-474x.151607.